This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages) |
Joan Bailey-Wilson | |
---|---|
Born | 1953 (age 70–71) |
Alma mater | Western Maryland College (B.A.) Indiana University School of Medicine (Ph.D.) |
Spouse | |
Children | 2 |
Scientific career | |
Fields | Statistical genetics |
Institutions | Medical Center of Louisiana at New Orleans National Human Genome Research Institute |
Doctoral advisor | Joe C. Christian |
Joan Ellen Bailey-Wilson (born 1953) is an American statistical geneticist. She is a senior investigator and co-chief of the Computational and Statistical Genomic Branch of the National Human Genome Research Institute.
Bailey-Wilson received a B.A. magna cum laude in Biology from Western Maryland College followed by a Ph.D. in medical genetics with a minor in biomathematics from Indiana University School of Medicine in 1981 under the direction of Joe C. Christian. She completed post-doctoral training with Robert Elston in the Department of Biometry and Genetics at Louisiana State University Medical Center. [1]
Bailey-Wilson became a professor at the Medical Center of Louisiana at New Orleans before joining the National Institutes of Health in 1995. She was appointed co-branch chief of the Inherited Disease Research Branch in 2006 and became co-chief of the Computational and Statistical Genomics Branch at the National Human Genome Research Institute in 2014. [1] Her research program focuses on understanding the genetic factors that increase risk for various complex diseases and their interactions with environmental risk factors. Bailey-Wilson specializes in statistical genetics and genetic epidemiology and is especially interested in risk factors for lung cancer, prostate cancer, eye disorders, autism and oral clefts. [2]
She has served on many scientific advisory boards including the Cancer Family Registry CFRCCS Advisory Board, the World Trade Center Kinship and Data Analysis Panel for the National Institute of Justice and the Genetic Analysis Workshop Advisory Board. She also served as a member of the International Genetic Epidemiology Society (IGES) Board of Directors (1999-2001), as IGES president-elect, president and past president (2006-2008) and as chair of the IGES Ethical, Legal and Social Issues committee. [1]
Bailey-Wilson is actively studying a range of diseases, including lung cancer, prostate cancer, myopia and other eye diseases, autism and cleft lip and palate. Trained in statistical genetics, she is interested in understanding the genetics of complex diseases and developing novel methodologies to disentangle the roles that genes and environment play in disease causation. She has been particularly interested in lung cancer since the early 1980s, when very few scientists believed there might be a genetic link to the condition. Today, significantly more data support the idea that there are susceptibility alleles for one or more unknown genes that dramatically increase certain smokers' risk of developing lung cancer. In a collaboration called the Genetic Epidemiology of Lung Cancer Consortium (GELCC), Bailey-Wilson and others recently narrowed down the location of a potential lung-cancer gene to a region of chromosome 6, and showed that RGS17 is a tumor suppressor gene in this region that shows association with lung cancer risk in highly aggregated lung cancer families. With her collaborators, she is using dense genotyping panels and next-generation DNA sequencing in the GELCC's set of highly aggregated lung cancer families, their family-history-positives cases, and age-gender-smoking matched controls to search for causal variants in additional lung cancer susceptibility loci. [1]
Bailey-Wilson has used similar approaches to locate other cancer-related genes. For example, she and her collaborators published evidence that genes involved in prostate cancer reside on specific regions of chromosomes 1, 8, 17 and X. These findings have been replicated, and three candidate genes with rare variants that appear to increase prostate cancer risk have been cloned: RNASEL (HPC1), which encodes ribonuclease L, MSRI, which encodes the macrophage scavenger receptor 1 and HOXB13, which encodes the homeobox B13 protein. Bailey-Wilson is focusing on identifying additional susceptibility genes for these and other cancers in ongoing studies. At present, she is collaborating with the International Consortium for Prostate Cancer Genetics on a whole exome sequencing study of families with strong family history of prostate cancer and is the lead statistician on the study of the ICPCG's African-American families. [1]
Bailey-Wilson is also applying these next-generation sequencing tools to her studies of highly aggregated non-syndromic oral cleft families from the Syrian Arab Republic (2 to 17 affected individuals per family) and to a set of multiplex autism spectrum disease families. In the autism study, a subset of families in which at least one child with autism also has abnormal cholesterol levels are of particular interest. [1]
Bailey-Wilson develops and tests novel computational methods to analyze genetic markers. Her group is especially interested in using machine learning methods to detect causal variants that have limited or no marginal effects on risk of a disease but which do show strong interaction effects (with either other genetic variants or with environmental risk factors). She is also working to address the effects of linkage disequilibrium, or the nonrandom association of closely spaced loci, on genetic interaction tests and machine learning methods. Linkage disequilibrium can be caused by a low frequency of recombinations between two loci when they are very close together on a chromosome. The closer two loci are, the more likely they are to exhibit linkage disequilibrium. Thus, markers that are only 100 kb apart display significantly greater linkage disequilibrium than markers that are 100–5,000 kb apart. Because standard linkage analysis methods typically assume no linkage disequilibrium exists between loci, Bailey-Wilson's group has developed approaches to streamline these methods to study sets of dense genetic markers. She is using association methods that take advantage of linkage disequilibrium data, HapMap data, and the sequence of the human genome to determine the location of genetic loci that increase risk for various diseases. She has used these and other analytical methods to determine, for example, whether alleles at specific marker loci are transmitted along with a disease through generations in families with several affected members. [1]
Bailey-Wilson has also used statistical methods to determine the marker alleles that people with a specific disease carry more frequently - and disease-free people carry less frequently - than can be explained by chance. This work has helped to greatly reduce the number of target regions that investigators need to search for potential disease-related genes. Her group is also developing approaches to mitigate the increased false-positive evidence of epistatic interaction that can be observed when strong LD exists between variants within a single genetic locus that all have a marginal effect on the trait. [1]
Bailey-Wilson has received a number of awards and honors, including the Distinguished Alumnus Award from the Department of Medical Genetics, Indiana University School of Medicine (1995), the Trustee's Alumni Award from Western Maryland College (1998), the Leadership Award from the International Genetic Epidemiology Society (2006), induction as an alumni member into Phi Beta Kappa (2010) and the NHGRI Outstanding Mentor Award (2011). Bailey-Wilson is a diplomat of the American Board of Medical Genetics and a founding fellow of the American College of Medical Genetics. [1]
Joan Bailey-Wilson and Alexander F. Wilson met as undergraduates while working with the sole genetics faculty member at Western Maryland College in Westminster, Maryland. One thing led to another, and they ended up attending graduate school together at Indiana University, where they studied medical genetics, mathematics, and computer science. [3]
They were married in 1978, and two years later they received their doctorates and went to Louisiana State University Medical School in New Orleans to work with Robert Elston. Elston is one of the leading figures in statistical genetics, a then-emerging field that draws on elements of epidemiology, genetics, molecular biology, computer science, and statistics. They entered LSU as postdoctoral fellows and stayed for 15 years, each ultimately reaching the rank of full professor. When Elston left LSU for Case Western Reserve University in Cleveland in 1995, Wilson and Bailey-Wilson decided to relocate as well, to NHGRI. [3]
Initially they were in separate branches—Wilson in the Genetic Disease Research Branch led by Robert Nussbaum and Bailey-Wilson in the Medical Genetics Branch led at the time by Clair Francomano. However, their work was so different from that of the other more traditional bench scientists in their branches that they posed an administrative challenge. [3]
"We don't purchase supplies; we make contracts for data collection. When we buy computers, it's not laptop computers, it's big servers," explained Wilson. [3]
So two years later, Wilson and Bailey-Wilson became a branch unto themselves—the Inherited Disease Research Branch (IDRB). Because NIH's anti-nepotism rules prohibit one spouse from supervising the other, Nussbaum was appointed acting chief of the branch. Over the years, Nussbaum gradually taught Wilson and Bailey-Wilson the administrative aspects of the chief's job; thus, they were well prepared to take over this year. "He trained us up," said Wilson. [3]
Co-branch chiefs are rare at the NIH; married co-chiefs are even rarer. Bailey-Wilson and Wilson have 2 children. [3]
Genetic linkage is the tendency of DNA sequences that are close together on a chromosome to be inherited together during the meiosis phase of sexual reproduction. Two genetic markers that are physically near to each other are unlikely to be separated onto different chromatids during chromosomal crossover, and are therefore said to be more linked than markers that are far apart. In other words, the nearer two genes are on a chromosome, the lower the chance of recombination between them, and the more likely they are to be inherited together. Markers on different chromosomes are perfectly unlinked, although the penetrance of potentially deleterious alleles may be influenced by the presence of other alleles, and these other alleles may be located on other chromosomes than that on which a particular potentially deleterious allele is located.
A quantitative trait locus (QTL) is a locus that correlates with variation of a quantitative trait in the phenotype of a population of organisms. QTLs are mapped by identifying which molecular markers correlate with an observed trait. This is often an early step in identifying the actual genes that cause the trait variation.
Genetic association is when one or more genotypes within a population co-occur with a phenotypic trait more often than would be expected by chance occurrence.
Medical genetics is the branch of medicine that involves the diagnosis and management of hereditary disorders. Medical genetics differs from human genetics in that human genetics is a field of scientific research that may or may not apply to medicine, while medical genetics refers to the application of genetics to medical care. For example, research on the causes and inheritance of genetic disorders would be considered within both human genetics and medical genetics, while the diagnosis, management, and counselling people with genetic disorders would be considered part of medical genetics.
In population genetics, an ancestry-informative marker (AIM) is a single-nucleotide polymorphism that exhibits substantially different frequencies between different populations. A set of many AIMs can be used to estimate the proportion of ancestry of an individual derived from each population.
Neil Risch is an American human geneticist and professor at the University of California, San Francisco (UCSF). Risch is the Lamond Family Foundation Distinguished Professor in Human Genetics, Founding Director of the Institute for Human Genetics, and Professor of Epidemiology and Biostatistics at UCSF. He specializes in statistical genetics, genetic epidemiology and population genetics.
In molecular biology, SNP array is a type of DNA microarray which is used to detect polymorphisms within a population. A single nucleotide polymorphism (SNP), a variation at a single site in DNA, is the most frequent type of variation in the genome. Around 335 million SNPs have been identified in the human genome, 15 million of which are present at frequencies of 1% or higher across different populations worldwide.
A tag SNP is a representative single nucleotide polymorphism (SNP) in a region of the genome with high linkage disequilibrium that represents a group of SNPs called a haplotype. It is possible to identify genetic variation and association to phenotypes without genotyping every SNP in a chromosomal region. This reduces the expense and time of mapping genome areas associated with disease, since it eliminates the need to study every individual SNP. Tag SNPs are useful in whole-genome SNP association studies in which hundreds of thousands of SNPs across the entire genome are genotyped.
In genomics, a genome-wide association study, is an observational study of a genome-wide set of genetic variants in different individuals to see if any variant is associated with a trait. GWA studies typically focus on associations between single-nucleotide polymorphisms (SNPs) and traits like major human diseases, but can equally be applied to any other genetic variants and any other organisms.
Homeobox protein engrailed-2 is a protein that in humans is encoded by the EN2 gene. It is a member of the engrailed gene family.
In genetics, association mapping, also known as "linkage disequilibrium mapping", is a method of mapping quantitative trait loci (QTLs) that takes advantage of historic linkage disequilibrium to link phenotypes to genotypes, uncovering genetic associations.
A gene is said to be polymorphic if more than one allele occupies that gene's locus within a population. In addition to having more than one allele at a specific locus, each allele must also occur in the population at a rate of at least 1% to generally be considered polymorphic.
Quantitative trait loci mapping or QTL mapping is the process of identifying genomic regions that potentially contain genes responsible for important economic, health or environmental characters. Mapping QTLs is an important activity that plant breeders and geneticists routinely use to associate potential causal genes with phenotypes of interest. Family-based QTL mapping is a variant of QTL mapping where multiple-families are used.
Jane M. Olson was an American genetic epidemiologist and biostatistician, "best known internationally for her contributions to advanced statistical methods in genetic epidemiology".
Nilanjan Chatterjee is a Bloomberg Distinguished Professor of Biostatistics and Genetic Epidemiology at Johns Hopkins University, with appointments in the Department of Biostatistics in the Bloomberg School of Public Health and in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center in the Johns Hopkins School of Medicine. He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
A human disease modifier gene is a modifier gene that alters expression of a human gene at another locus that in turn causes a genetic disease. Whereas medical genetics has tended to distinguish between monogenic traits, governed by simple, Mendelian inheritance, and quantitative traits, with cumulative, multifactorial causes, increasing evidence suggests that human diseases exist on a continuous spectrum between the two.
In genetics, a polygenic score (PGS) is a number that summarizes the estimated effect of many genetic variants on an individual's phenotype. The PGS is also called the polygenic index (PGI) or genome-wide score; in the context of disease risk, it is called a polygenic risk score or genetic risk score. The score reflects an individual's estimated genetic predisposition for a given trait and can be used as a predictor for that trait. It gives an estimate of how likely an individual is to have a given trait based only on genetics, without taking environmental factors into account; and it is typically calculated as a weighted sum of trait-associated alleles.
Complex traits, also known as quantitative traits, are traits that do not behave according to simple Mendelian inheritance laws. More specifically, their inheritance cannot be explained by the genetic segregation of a single gene. Such traits show a continuous range of variation and are influenced by both environmental and genetic factors. Compared to strictly Mendelian traits, complex traits are far more common, and because they can be hugely polygenic, they are studied using statistical techniques such as quantitative genetics and quantitative trait loci (QTL) mapping rather than classical genetics methods. Examples of complex traits include height, circadian rhythms, enzyme kinetics, and many diseases including diabetes and Parkinson's disease. One major goal of genetic research today is to better understand the molecular mechanisms through which genetic variants act to influence complex traits.
In genetic epidemiology, family studies are studies of whether a disease or trait "runs in a family". In other words, they are studies aimed at detecting the presence or absence of familial aggregation for the disease or trait, in which having a family history is associated with greater risk. The family research design can also be used to estimate penetrance for a given genotype, to conduct genetic association studies, and to study potential modifiers of an individual's genetic risk. If a family study shows that a trait is familial, this is a necessary, but not sufficient, criterion for it to be established as genetically influenced.
Stephanie J. London is an American epidemiologist and physician-scientist specializing in environmental health, respiratory diseases, and genetic susceptibility. She is the deputy chief of the epidemiology branch at the National Institute of Environmental Health Sciences.